JPWO2022075347A1 - - Google Patents

Info

Publication number
JPWO2022075347A1
JPWO2022075347A1 JP2022555521A JP2022555521A JPWO2022075347A1 JP WO2022075347 A1 JPWO2022075347 A1 JP WO2022075347A1 JP 2022555521 A JP2022555521 A JP 2022555521A JP 2022555521 A JP2022555521 A JP 2022555521A JP WO2022075347 A1 JPWO2022075347 A1 JP WO2022075347A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022555521A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022075347A1 publication Critical patent/JPWO2022075347A1/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
JP2022555521A 2020-10-07 2021-10-06 Pending JPWO2022075347A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020170099 2020-10-07
PCT/JP2021/036912 WO2022075347A1 (en) 2020-10-07 2021-10-06 Method for producing octahydrothienoquinoline compound, and production intermediate of same

Publications (1)

Publication Number Publication Date
JPWO2022075347A1 true JPWO2022075347A1 (en) 2022-04-14

Family

ID=81125994

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022555521A Pending JPWO2022075347A1 (en) 2020-10-07 2021-10-06

Country Status (4)

Country Link
JP (1) JPWO2022075347A1 (en)
CN (1) CN116348470A (en)
TW (1) TW202229290A (en)
WO (1) WO2022075347A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI537274B (en) * 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 Novel octahydrothienoquinoline derivatives, pharmaceutical compositions containing the same, and their uses
JP6177061B2 (en) * 2012-09-12 2017-08-09 キッセイ薬品工業株式会社 Novel dopamine D2 receptor agonist
JP6166990B2 (en) * 2012-09-12 2017-07-19 キッセイ薬品工業株式会社 Process for producing octahydrothienoquinoline derivative and its intermediate
EP2930175A4 (en) * 2012-12-10 2016-12-21 Kissei Pharmaceutical Novel octahydropyridoquinazoline derivative, pharmaceutical composition containing same, and uses for said derivative and composition
WO2014112492A1 (en) * 2013-01-17 2014-07-24 キッセイ薬品工業株式会社 Novel octahydroquinoline derivative, pharmaceutical composition containing same, and use thereof
JP2014172873A (en) * 2013-03-11 2014-09-22 Kissei Pharmaceutical Co Ltd Novel octahydroquinoline derivatives, pharmaceutical compositions containing the same, and their applications
JP2016011291A (en) * 2014-06-04 2016-01-21 キッセイ薬品工業株式会社 Novel dopamine D2 receptor agonist
JP2016160206A (en) * 2015-03-02 2016-09-05 キッセイ薬品工業株式会社 New ureide carbonyl octahydroquinoline derivative, pharmaceutical composition containing the same and application thereof

Also Published As

Publication number Publication date
CN116348470A (en) 2023-06-27
TW202229290A (en) 2022-08-01
WO2022075347A1 (en) 2022-04-14

Similar Documents

Publication Publication Date Title
BR112023005462A2 (en)
BR112021014123A2 (en)
BR112023012656A2 (en)
BR112022024743A2 (en)
BR112022009896A2 (en)
BR102021007058A2 (en)
BR102020022030A2 (en)
BR112023011738A2 (en)
BR112023016292A2 (en)
BR112023004146A2 (en)
BR112023011539A2 (en)
BR112023011610A2 (en)
BR112023008976A2 (en)
BR112023009656A2 (en)
BR112023006729A2 (en)
BR102021020147A2 (en)
BR102021013929A2 (en)
BR112021017747A2 (en)
BR102021012571A2 (en)
BR102021012230A2 (en)
BR102021012107A2 (en)
BR102021012003A2 (en)
BR112021013417A2 (en)
BR102021010467A2 (en)
BR102021009555A2 (en)